Skip to content
The Senate Health, Education, Labor and Pensions (HELP) Committee marked up its legislation to reauthorize the Food and Drug Administration (FDA) user fee agreements, […]
FDA user fee bill marked up by Senate HELP Committee Read More »
Remarks from Paul Hastings, CEO of Nkarta Therapeutics and Chairman of the Biotechnology Innovation Organization (BIO), as prepared for delivery at the BIO International
The South Carolina Biotechnology Industry Organization (SCBIO) is pleased to announce the launch of its first-in-kind, next-generation life sciences workforce development mobile app, undertaken
SCBIO launches ‘Rad Lab’ life sciences workforce app Read More »
The FDA’s Accelerated Approval Pathway must be preserved against current threats as it has been a lifeline for patients with rare diseases, life-threatening conditions,
FDA Accelerated Approval Pathway must be preserved, experts say Read More »
The COVID-19 pandemic brought anxiety and uncertainty worldwide, and also created challenges from social isolation to supply chain issues to economic instability, which worsened
BIO Unbound: ‘Science is limitless when we limit science less’ Read More »
Biofuel producer POET said last week that it anticipates half of its biofuel facilities will meet their climate targets ahead of schedule, according to
Biofuel producer POET to meet climate goals ahead of schedule Read More »
Biotechnology as a sector has a massive impact on Environmental, Social, and Governance (ESG) issues, but one area of growing importance to biotech is
Biotech has the power to impact ESG issues Read More »
The health care sector is not being hit by overall inflation – and prescription drug prices are seeing the lowest increases, says a new
Inflation’s not hitting health – and drug prices have lowest increases, says report Read More »
The Biopharma Sustainability Roundtable published a guidance document which expands on strategic thinking and planning of biotechnology and pharma investor Environmental, Social, and Governance
How biopharma can better communicate about ESG Read More »
The U.S. Federal Trade Commission (FTC) announced last week that it will investigate the “prescription drug middleman industry,” demanding information and records regarding the
FTC will investigate six largest pharmacy benefit managers Read More »
